Management of breakthrough bleeding in extended hormonal contraceptive regimens

Management of breakthrough bleeding in extended hormonal contraceptive regimens

  • CN 1,950,092 A
  • Filed: 04/29/2005
  • Published: 04/18/2007
  • Est. Priority Date: 04/30/2004
  • Status: Active Application
First Claim
Patent Images

1. , a kind of estrogen method of contraception, its be included in the ethinylestradiol of single-phase in first short period of described women'"'"'s Len req, successive administration 5 to<

  • 30 μ

    g amount or be equivalent to 5 to<

    30 μ

    g ethinylestradiol amounts to described women other synthesize or the active ingredient of the progestogen of natural estrogen and contraception amount, described then women began the described active ingredient of interruption of the administration 1 to 6 day, and had no progeny in wherein said and have at least a persistent period to be at least the most short-period first further administration cycle.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×